Princeton, NJ, United States of America

Denette K Murphy

This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Denette K Murphy. Retrieved from https://idiyas.com/inventor/denette-k-murphy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Denette K Murphy: Innovator in Pharmaceutical Chemistry

Introduction

Denette K Murphy is a notable inventor based in Princeton, NJ (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications.

Latest Patents

Denette holds a patent for "Crystalline forms of a factor Xa inhibitor." This invention provides crystalline forms of 1-(3-chlorophenyl)-7-oxo-6-[4-(2-oxo-1(2H)pyridinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide and its solvates. The patent also details processes for producing these crystalline forms, pharmaceutical compositions that include them, and methods for treating thromboembolic disorders using these compositions. She has 1 patent to her name.

Career Highlights

Denette K Murphy is associated with Bristol-Myers Squibb Company, where she has been instrumental in advancing research and development in pharmaceuticals. Her work has had a significant impact on the treatment of various medical conditions.

Collaborations

Throughout her career, Denette has collaborated with esteemed colleagues, including Margaret M Gleeson and Gary McGeorge. These partnerships have fostered innovation and contributed to the success of her projects.

Conclusion

Denette K Murphy exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions, particularly in the development of factor Xa inhibitors, highlight her role as a leading inventor in her field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…